API Holdings Limited
Current Price
Current Price
Min. Lot Size
5000
Price Performance
PharmEasy is one of India's premier digital healthcare platforms, dedicated to making healthcare accessible and affordable. Founded in 2015, it connects patients with local pharmacies and diagnostic centers through an easy-to-use app and website. The platform offers a wide array of services, including doorstep delivery of prescription medicines, over-the-counter products, and wellness items. Beyond pharmacy services, PharmEasy provides convenient at-home diagnostic testing and teleconsultations with registered doctors. By bridging the gap between healthcare providers and consumers, PharmEasy has revolutionized Indian healthcare delivery, reliably serving millions of users across thousands of pin codes nationwide.
6 months after listing for Pre-IPO investors.
Yes, 100% digital transfer to your CDSL/NSDL Demat account.
You can buy PharmEasy Unlisted Shares unlisted shares through IPO360. Simply initiate a request via our WhatsApp channel, submit your Client Master Report (CMR) for Demat verification, make a secure payment, and the shares will be credited directly to your CDSL/NSDL Demat account within 24 hours.
The current live rate for PharmEasy Unlisted Shares unlisted shares is ₹5.10. Prices in the unlisted market are subject to market demand, company performance, and liquidity, and are updated regularly on IPO360.
Yes, the minimum lot size for PharmEasy Unlisted Shares unlisted shares is 5000.
You can check detailed financial performance, key fundamentals, and balance sheets for PharmEasy Unlisted Shares directly on the IPO360 dedicated company page. All financial metrics are verified against audited financial statements via MCA filings.
Once payment is confirmed and the required Demat details (CMR copy) are verified, the transfer of PharmEasy Unlisted Shares unlisted shares to your Demat account is initiated immediately and completed within 24 hours.
Join the discussion!
Log In to CommentCurrent Price
₹5.10
No comments yet. Be the first to share your thoughts!